We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Modified Version of CRISPR/Cas9 Identifies Parasite Infectivity Genes

By LabMedica International staff writers
Posted on 13 Sep 2016
A modified version of the CRISPR/Cas9 gene editing system was used to map the genome of the apicomplexan parasite Toxoplasma gondii, which, in addition to revealing which genes were necessary for this pathogen's survival, gave insights into genes necessary for infection by the malaria parasite Plasmodium falciparum.

CRISPRs (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. More...
Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacterial virus or plasmid. CRISPRs are found in approximately 40% of sequenced bacteria genomes and 90% of sequenced archaea. CRISPRs are often associated with cas genes that code for proteins related to CRISPRs. Since 2013, the CRISPR/Cas system has been used in research for gene editing (adding, disrupting, or changing the sequence of specific genes) and gene regulation. By delivering the Cas9 enzyme and appropriate guide RNAs (sgRNAs) into a cell, the organism's genome can be cut at any desired location. The conventional CRISPR/Cas9 system is composed of two parts: the Cas9 enzyme, which cleaves the DNA molecule and specific RNA guides that shepherd the Cas9 protein to the target gene on a DNA strand.

In the current study, investigators at the Whitehead Institute (Cambridge, MA, USA) modified CRISPR/Cas9 to reduce the overall damage caused to the T. gondii genome while increasing the precision of its gene targeting. This approach allowed them to assess the contribution of each of T. gondii’s 8,158 genes and study their individual functions during infection of human fibroblasts.

Results published in the September 1, 2016, online edition of the journal Cell revealed approximate 200 genes common to all apicomplexans that contributed to the parasites’ ability to infect human cells. The investigators were particularly interested in a gene called claudin-like apicomplexan microneme protein (CLAMP), which encoded an invasion factor that resembled mammalian tight-junction proteins and localized to secretory organelles, making it critical to the initiation of infection. They reported that CLAMP was present throughout sequenced apicomplexan genomes and was essential during the asexual stages of the malaria parasite Plasmodium falciparum.

“There has never been a really good way of looking at the function of all genes in any apicomplexan parasite,” said senior author Dr. Sebastian Lourido a fellow of the Whitehead Institute. “We have introduced a method to assess the function of the entire genome. This technology can be used to study a variety of topics, from nutrient acquisition and responses to immune pressures to epistasis and genetic interactions. This is an important leap forward in what is possible to investigate in these parasites.”

Related Links:
Whitehead Institute



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.